E2F1, E2F transcription factor 1, can be one of the ferroptosis-related gene prognostic indexes (FRGPI) to predict disease-free survival (DFS) for PCa patients undergoing radical prostatectomy. This evidence concerns the gene E2F1 and posterior cortical atrophy.